Filter by patients with: All

What is Lenalidomide-dexamethasone (Rd)?

Category: Prescription Drugs

false

See also: Dexamethasone Lenalidomide

Lenalidomide-dexamethasone, also known as Rd, is a regimen that may be used for the treatment of multiple myeloma. It includes lenalidomide, an anticancer agent, and dexamethasone, a corticosteroid.

See patients taking Lenalidomide-dexamethasone (Rd)

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Multiple myeloma 425 27
Depressed mood 1 0
POEMS syndrome 1 2
  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
See all 452 patients that have taken Lenalidomide-dexamethasone (Rd)

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 3
Moderate 17
Mild 6
None 3

Commonly reported side effects and conditions associated with Lenalidomide-dexamethasone (Rd)

Side effect Patients Percentage
Fatigue 4
Nausea 3
Chronic constipation 2
Chronic fatigue 2
Diarrhea 2
Muscle cramps 2

Show all 37 reported side effects

Why patients stopped taking Lenalidomide-dexamethasone (Rd)

Multiple reasons could be selected

Reason Patients Percentage
Course of treatment ended 4
Doctor's advice 3
Side effects too severe 3
Other 2
Did not seem to work 1
See all 9 patients who've stopped taking Lenalidomide-dexamethasone (Rd)

Duration

Stopped taking Lenalidomide-dexamethasone (Rd)

Duration Patients Percentage
Less than 1 month 1
1 - 6 months 5
6 months - 1 year 1
2 - 5 years 2
Adherence
Adherence Evaluations Percentage
Always 24
Usually 1
Sometimes 1
Never taken as prescribed 3
Burden
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 1
A little hard to take 4
Not at all hard to take 24
Cost per month
Cost per month Evaluations Percentage
$200+ 3
$100-199 0
$50-99 1
$25-49 4
< $25 6
Not specified 15

What people switch to and from

Patients started taking Lenalidomide-dexamethasone (Rd) after stopping:

Treatment Patients Percentage
Bortezomib-cyclophosphamide-dexamethasone (VCd or CyBorD) 6
Bortezomib (Velcade) 1
Thalidomide-dexamethasone (Td) 1

Patients stopped taking Lenalidomide-dexamethasone (Rd) and switched to:

Treatment Patients Percentage
Bortezomib (Velcade) 2
Lenalidomide (Revlimid) 2
Bortezomib-dexamethasone (Vd) 1
Bortezomib-lenalidomide-dexamethasone (VRd) 1
Carfilzomib-lenalidomide-dexamethasone 1
Last updated:

1 patient evaluation for Lenalidomide-dexamethasone (Rd)

Sort by: Most recent

Sep 27, 2017 (Started Nov 16, 2015)

  • Effectiveness
    Major (for multiple myeloma)
  • Side effects
    Moderate (skin irritation, nausea, chronic fatigue)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: Daily
Cost: $200+ monthly

Oct 6, 2016 (Started Nov 16, 2015)

  • Effectiveness
    Major (for multiple myeloma)
  • Side effects
    Moderate (skin irritation, nausea, chronic fatigue)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: Daily

Dec 11, 2015 (Started Nov 16, 2015)

  • Effectiveness
    Major (for multiple myeloma)
  • Side effects
    Mild (skin irritation, nausea, chronic fatigue)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: Daily
  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Lenalidomide-dexamethasone (Rd)